The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice
Publication date
2025-02
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Decentralized clinical trial (DCT) approaches – in which trial activities are conducted at participants’ homes – have the potential to improve representativeness. We present a study that compared the demographics and cardiovascular risk factors of participants from a DCT (ASCEND) and a conventional trial with a similar trial objective (POPADAD) to those of patients in daily practice. We adjudicate that there are relevant differences when comparing the participants of the conventional trial and the DCT, with the latter providing better representativeness in terms of age, insulin use, smoking status, and body mass index, whereas conventional trial participants were more representative in terms of biological sex. Differences in these characteristics were not explained by the eligibility criteria, but are considered attributable to the operational trial approach.
Keywords
clinical trial operations, decentralized clinical trials, generalizability, participant representativeness, Pharmacology, Drug Discovery, Journal Article, Comparative Study, Review
Citation
de Jong, A J, Zuidgeest, M G P, Santa-Ana-Tellez, Y, Hallgreen, C E, van Sloten, T T, de Boer, A, Gardarsdottir, H & the Trials@Home Consortium 2025, 'The impact of operational trial approaches on representativeness : Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice', Drug Discovery Today, vol. 30, no. 2, 104304. https://doi.org/10.1016/j.drudis.2025.104304